Outcomes of CTAK Surgery

Outcomes of Corneal Tissue Addition for Keratoplasty (CTAK) in Patients With Ectatic Corneas

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07474870

Acronym

CTAK

Enrollment

100

Registered

2026-03-16

Start date

2026-05-01

Completion date

2031-01-01

Last updated

2026-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Ectasia, Keratoconus

Keywords

CTAK, Corneal Ectasia

Brief summary

Measuring quality of vision and quality of life outcomes using a validated questionnaire in participants undergoing CTAK surgery for corneal ectasia

Detailed description

The investigators are measuring self-reported quality of vision and quality of life outcomes in participants undergoing CTAK surgery for corneal ectasia

Interventions

BEHAVIORALQuestionnaire and Physical Exam

Patient reported outcomes of CTAK surgery

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Intervention model description

Preoperative and postoperative questionnaire

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Corneal Ectasia and Keratoconus

Exclusion criteria

* Excessively thin cornea * Significant corneal scarring

Design outcomes

Primary

Measure	Time frame	Description
Questionnaire	One year	Preoperative and postoperative questionnaire

Countries

United States

Contacts

CONTACTEdward Manche, MD

edward.manche@stanford.edu16504987020

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 25, 2026